Pfizer asks FDA for authorization for COVID-19 vaccine for young children

Photo: portishead1/Getty Photos

Pfizer and BioNTech have requested the Meals and Drug Administration for crisis use authorization for a COVID-19 vaccine for small children ages 6 months to 4 several years old.

This has been completed at the ask for of the Fda, Pfizer said yesterday.

“With pediatric COVID-19 circumstances surpassing 10 million and at the request of the Fda, the providers have submitted readily available knowledge on the basic safety and efficacy of two 3 µg doses as component of a 3-dose principal series for this age team to address the urgent public health and fitness want,” they said.

The providers strategy to post added data on a 3rd 3 µg dose in this age team in the coming months.

WHY THIS Matters

If authorization is granted, the Pfizer-BioNTech vaccine would be the very first COVID-19 vaccine offered for pediatric populations less than 5 a long time of age.

Read More